GeoVax shareholders approve issuance of up to 3.78M shares upon warrant exercises in two private placements

GeoVax Labs, Inc.

May 2024 warrant exercise proposal approved: 1,294,141 for, 287,649 against, 93,544 abstain.
July 2024 warrant exercise proposal approved: 1,306,150 for, 275,705 against, 93,479 abstain.
Total shares issuable if both warrants exercised: up to 1,605,688 (May) + 2,170,000 (July) = 3,775,688 shares.
Only 33.4% of outstanding shares (1,675,334 of 5,013,700) were voted at the reconvened special meeting.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.